Food and Drug Administration

Claims That the FDA Has Approved Ivermectin to Treat COVID-19 Are False – Peter Gattuso

by

The Ivermectin Controversy: A Lens on Public Health Policy and Misinformation The ongoing debate over ivermectin, a medication traditionally used for parasitic infections, offers profound insights into public health policy, misinformation, and patient treatment options. The recent resurgence of claims regarding its FDA approval for COVID-19 treatment reflects deeper trends that are shaping healthcare communication … Read more

Tiny Drugmaker Soars on FDA Win to Treat Never-Ending Hunger

by

A Breakthrough for Soleno Therapeutics: A New Hope for Prader-Willi Syndrome In a trailblazing move, Soleno Therapeutics has achieved a significant milestone with the FDA approval of Vykat XR. This new drug offers renewed hope for adults and children battling hyperphagia, a relentless hunger linked to the genetic Prader-Willi syndrome. Understanding Prader-Willi Syndrome and Hyperphagia … Read more

F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

by

Expanding Access to Clozapine: A New Era for Treatment-Resistant Schizophrenia The recent shift in FDA policy to eliminate pre-prescription blood tests for clozapine marks a significant milestone for patients with treatment-resistant schizophrenia, offering a beacon of hope for those who have long struggled with the availability of this potent medication. The Promise of Clozapine Clozapine, … Read more

How cancer research advances, from better screening to improved vaccines, are saving lives

by

The Golden Age of Cancer Research: Understanding the Advancements The landscape of cancer research and treatment is rapidly evolving, with significant progress being made. As we mark World Cancer Day, Cancer Research UK heralds the dawn of the “golden age of cancer research.” This era is characterized by groundbreaking scientific advancements that hold promise for … Read more

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

by

Revolutionary New Nonaddictive Pain Medication Approved by FDA The FDA has approved a groundbreaking new medication, suzetrigine (sold as Journavx), created by Vertex Pharmaceuticals, marking a significant advancement in pain management. Unlike traditional opioid painkillers, suzetrigine is designed to alleviate pain without the risk of addiction, operating exclusively outside the brain to block pain signals. … Read more

Outgoing FDA chief flags online weight loss drug dangers

by

The Rise of Compounded Weight Loss Drugs: A Growing Concern The increasing popularity of compounded weight loss drugs, especially those purchased online, has raised significant concerns for public health. Outgoing FDA Commissioner Robert Califf has highlighted gaps in current laws and regulations that could leave Americans vulnerable to risks associated with these drugs. As these … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]